Aptamer-modified Magnetic Nanosensitizer for in vivo MR imaging of HER2-expressing Cancer

Aptamer-modified Magnetic Nanosensitizer for in vivo MR imaging of HER2-expressing Cancer

Abstract The aim of this study was the development of a human epidermal growth factor receptor 2 (HER2)-targetable contrast agent for magnetic resonance imaging (MRI) with a high magnetic sensitivity. An anti-HER2 aptamer-modified magnetic nanosensitizer (AptHER2-MNS) was prepared by conjugation wit...

Full description

Bibliographic Details
Main Authors: Dan Heo, Minhee Ku, Jung-Hoon Kim, Jaemoon Yang, Jin-Suck Suh
Format: Article
Language:English
Published: SpringerOpen 2018-09-01
Series:Nanoscale Research Letters
Subjects:
Magnetic resonance imaging
Breast cancer
HER2
Aptamer
Contrast agent
Molecular imaging
Online Access:http://link.springer.com/article/10.1186/s11671-018-2682-3

Internet

http://link.springer.com/article/10.1186/s11671-018-2682-3

Similar Items